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Aire in the periphery
The autoimmune regulator gene (Aire) is critical for 
immunological tolerance to self in the thymus via regu lation 
of tissue-specific self-antigens; however, the prevention of 
autoimmunity must also continue following T-lymphocyte 
migration out of the thymus. Gardner and colleagues recent-
ly identified a population of extrathymic Aire-expressing cells 
(eTACs) in T-cell zones of the secondary lymphoid organs. In 
these cells, which are of stromal origin, Aire regulated the 
expression of a distinct set of self-antigens in the periphery. 
Furthermore, these eTACs promoted tolerance through sta-
ble interactions with naive autoreactive T cells entering the 
lymph nodes, resulting in rapid proliferation and deletion of 
these T cells. These findings suggest that eTACs function as a 
safety net in the periphery to promote immune tolerance via 
elimination of errant autoreactive T cells that have escaped 
negative selection in the thymus. (Science 321:843–7, 2008)
Peptide blockade
The adhesion molecules desmoglein (Dsg) 3 and 1 are the 
primary targets of autoantibodies in pemphigus vulgaris (PV). 
These PV autoantibodies block the transinteraction of Dsg3; 
however, the specific pathogenic mechanism of this mucosal-
dominant disease remains cryptic. Heupel and colleagues 
therefore designed a tandem peptide consisting of two single 
peptides predicted to fit the most likely Dsg adhesive interface 
tethered together via a flexible linker. Indeed, this peptide 
prevented the effects of PV-IgG on Dsg3 adhesion and, more 
importantly, attenuated the PV-IgG-induced acantholysis 
in human keratinocytes in culture. Thus, direct inhibition of 
Dsg3 transinteraction plays a significant role in the pathogen-
esis of PV. These results encourage the development of similar 
peptidomimetics for the treatment of pemphigus, as well as 
other autoantibody-mediated diseases that affect cell adhe-
sion molecule function. ( J Biol Chem 284:8589–95, 2009)
Dead cell antigens
To provoke an inflammatory response to initiate tissue repair, 
apoptotic cell clearance occurs, resulting in an accumulation 
of necrotic corpses. Antigens in these dead cells may insti-
gate specific immune responses. Previous work indicated 
that CD8α+ dendritic cells phagocytose dead cell fragments 
to cross-prime CD8+ T cells against these antigens. Sancho 
and colleagues next determined that CLEC9A, a C-type lec-
tin, on these CD8α+ dendritic cells recognized a preformed 
protein-associated ligand that was exposed during necrosis. 
Although CLEC9A was not required for uptake of necrotic cell 
remnants, this receptor was critical for cross-presentation of 
necrotic cell-associated antigens by CD8α+ dendritic cells. In 
addition, CLEC9A, which signals via the SYK tyrosine kinase 
pathway, was also essential for cross-priming T cells to anti-
gens associated with dead cells in mice. Therefore, CLEC9A 
on dendritic cells translates an innate recognition of cellular 
ligands exposed on necrotic cells into an adaptive immune 
response. (Nature 458:899–903, 2009)
T-to-B talk
The production of IgG stems from an interaction between 
T cells and B cells. IgG is instrumental in infectious diseases, 
organ transplantation, and autoimmune diseases, includ-
ing pemphigus vulgaris (PV). In this blistering disease, IgG 
autoantibodies are typically directed against the cell adhe-
sion molecule desmoglein 3 (Dsg3). Although Dsg3-reactive 
T cells are thought to function in the pathogenesis of PV, 
the interaction between these T cells and B cells to induce 
anti-Dsg3 antibody production has not been demonstrated 
in vivo. Takahashi and colleagues recently demonstrated that 
pathogenic T-cell clones could, in fact, prime naive B cells 
and induce anti-Dsg3 IgG production. Furthermore, adoptive 
transfer of these T cells with unprimed B cells induced the 
PV phenotype in mice. Interestingly, the induced anti-Dsg3 
IgG antibodies were polyclonal and exhibited an epitope 
distribution similar to that induced from antigen-primed 
B cells. These findings will likely spur development of ther-
apeutic strategies to target the mediating T-cell population 
that is at the source of detrimental autoimmune responses. 
( J Immunol 182:1740–5, 2009)
To screen or not to screen
To do no harm is a precept of medical practice. On the 
basis of this doctrine, the US Preventive Services Task Force 
(USPSTF) issues recommendations regarding preventive care 
for patients who do not exhibit signs or symptoms of a tar-
get condition. In February 2009, this group concluded that 
the accumulated body of evidence was insufficient to recom-
mend whole-body skin examinations by primary care physi-
cians or patient self-examinations for early detection of skin 
cancer in the adult general population. Skin cancer, includ-
ing basal cell carcinoma, squamous cell carcinoma, and mel-
anoma, is the most commonly diagnosed cancer, but the task 
force noted that screening has been only moderately accurate 
in detecting the most dangerous of these cancers, melano-
ma. Definitive studies comparing screened and unscreened 
populations with regard to health outcomes are lacking. 
Unfortunately, the benefits of improved detection, early treat-
ment, and improved morbidity and mortality, as well as the 
potential harms of increased biopsies, misdiagnoses, and 
unnecessary treatments, are not corroborated by research 
that is sufficient to support a formal recommendation by the 
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